RYBELSUS

This brand name is authorized in Brazil, Canada, Estonia, Spain, Finland, France, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Netherlands, Poland, Romania, Turkey, United Kingdom, United States

Active ingredients

The drug RYBELSUS contains one active pharmaceutical ingredient (API):

1 Semaglutide
UNII 53AXN4NNHX - SEMAGLUTIDE

Semaglutide is a GLP-1 receptor agonist. It acts in the same way as GLP-1 (a hormone produced in the gut) by increasing the amount of insulin that the pancreas releases in response to food. This helps with the control of blood glucose levels.

Read about Semaglutide

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
RYBELSUS Tablet FDA, National Drug Code (US) MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
A10BJ06 A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BJ Glucagon-like peptide-1 (GLP-1) analogues
Discover more medicines within A10BJ06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 526620120008707, 526620120008807, 526620120008907, 526620120009007, 526620120009107, 526620120009207, 526620120009307, 526620120009407, 526620120009507, 526620120009607, 526620120009707, 526620120009807
Country: CA Health Products and Food Branch Identifier(s): 02497581, 02497603, 02497611
Country: EE Ravimiamet Identifier(s): 1815814, 1815825, 1815836, 1815847, 1815869, 1815870, 1815881, 1815892, 1815904, 1815915
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 1201430002, 1201430005, 1201430008
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 047094, 146870, 383205, 439552, 478961
Country: FR Base de données publique des médicaments Identifier(s): 64596449, 66639842, 67593141
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 387319, 387322, 387325
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 8786, 8787, 8788
Country: IT Agenzia del Farmaco Identifier(s): 048719013, 048719025, 048719037, 048719049, 048719052, 048719064, 048719076, 048719088, 048719090, 048719102, 048719114, 048719126, 048719138, 048719140, 048719153
Country: JP 医薬品医療機器総合機構 Identifier(s): 2499014F1021, 2499014F2028, 2499014F3024
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1089852, 1089853, 1089854, 1089855, 1089856, 1089857, 1089858, 1089859, 1089860, 1089861, 1091558, 1091559, 1091560
Country: NL Z-Index G-Standaard, PRK Identifier(s): 203394, 203408, 203416
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100434043, 100434050, 100434066
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W66741001, W66741002, W66741003, W66741004, W66742002, W66742003, W66742004, W66743001, W66743002, W66743003
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8699676011230, 8699676011247, 8699676011254, 8699676011261, 8699676011278, 8699676011285, 8699676011292, 8699676011308, 8699676011315
Country: US FDA, National Drug Code Identifier(s): 0169-4303, 0169-4307, 0169-4314

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.